Quality assurance of radiotherapy in a clinical trial for lymphoma: Individual case review

Anticancer Research

Volumn 27, Issue 4 C, 2007, Pages 2621-2625

  Shikama, Naoto ^a   Oguchi, Masahiko ^b   Isobe, Koichi ^c   Nakamura, Katsumasa ^d   Tamaki, Yoshio ^e   Hasegawa, Masatoshi ^f   Kodaira, Takeshi ^g   Sasaki, Shigeru ^a   Kagami, Yoshikazu ^h  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c CHIBA UNIVERSITY HOSPITAL   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e GUNMA PREFECTURAL CANCER CENTER   (Japan)

^f NARA MEDICAL UNIVERSITY   (Japan)

^g AICHI CANCER CENTER HOSPITAL   (Japan)

^h NATIONAL CANCER CENTER   (Japan)

Author keywords

Aggressive lymphoma; Elderly patients; Quality assurance; Radiotherapy

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISOLONE; VINCRISTINE;

AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; HUMAN; LYMPHOMA; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; QUALITY CONTROL; RADIATION DOSE; TREATMENT DURATION; TREATMENT PLANNING; TREATMENT RESPONSE;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; CYCLOPHOSPHAMIDE; DOXORUBICIN; HUMANS; LYMPHOMA, NON-HODGKIN; PREDNISONE; QUALITY ASSURANCE, HEALTH CARE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; VINCRISTINE;

EID: 34547798660     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Miller TP: The limits of limited stage lymphoma. J Clin Oncol 22: 2982-2984, 2004.
2. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329: 987-994, 1993.
3. Gomez H, Hidalgo M, Casanova L et al: Risk factors for treatment-related death in elderly patients with aggressive non-Hodgkin's lymphoma: results of a multivariate analysis. J Clin Oncol 16: 2065-2069, 1998.
4. Kwak LW, Halpern J, Olshen RA et al: Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: results of a tree-structured survival analysis. J Clin Oncol 8: 963-977, 1990.
5. Shikama N, Oguchi M, Isobe K et al: A prospective study of reduced-dose three-course CHOP followed by involved-field radiotherapy for patients 70 years old or more with localized aggressive non-Hodgkin's lymphoma. Int J Radiat Oncol Biol Phys 66: 217-222, 2006.
6. Wallner PE, Lustig RA, Pajak TF et al: Impact of initial quality control review on study outcome in lung and head/neck cancer studies - review of the Radiation Therapy Oncology Group experience. Int J Radiat Oncol Biol Phys 17: 893-900, 1989.
7. Bolla M, Bartelink H, Garavaglia G et al: EORTC guidelines for writing protocols for clinical trials of radiotherapy. Radiother Oncol 36: 1-8, 1995.
8. Martin LA, Krall JM, Curran WJ et al: Influence of a sampling review process for radiation oncology quality assurance in cooperative group clinical trials - results of the Radiation Therapy Oncology Group (RTOG) analysis. Radiother Oncol 36: 9-14, 1995.
9. Eich HT, Staar S, Gossmann A et al: Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group. Int J Radiat Oncol Biol Phys 58: 1121-1127, 2004.
10. Cheson BD, Horning SJ, Coiffier B et al: Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol 17: 1244-1253, 1999.
11. Duhmke E, Diehl V, Loeffler M et al: Randomized trial with early-stage Hodgkin's disease testing 30 Gy vs. 40 Gy extended field radiotherapy alone. Int J Radiat Oncol Biol Phys 36: 305-310, 1996.
12. Roos DE, Davis SR, Turner SL et al: Quality assurance experience with the randomized neuropathic bone pain trial (Trans-Tasman Radiation Oncology Group, 96.05). Radiother Oncol 67: 207-212, 2003.
13. Valley JF, Bernier J, Tercier PA et al: Quality assurance of the EORTC radiotherapy trial 22931 for head and neck carcinomas: the dummy run. Radiother Oncol 47: 37-44, 1998.
14. Kouloulias VE: Quality assurance in radiotherapy. Eur J Cancer 39: 415-422, 2003.